Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InLoop is an Australian private technology company that develops payments and data platforms for complex, high-care environments, including healthcare, disability, aged care, education, government, and corporate markets. Its healthcare relevance comes primarily from LanternPay, a digital claiming and payment platform built to simplify multi-scheme claims and payments across healthcare, disability, insurance, Medicare, and NDIS workflows. The company positions itself as a fintech and data platform business rather than a drug developer, with commercialized software products already in market. InLoop has also built and operated Flexischools and analytics offerings such as Nuonic, and historically sold LanternPay to NAB's HICAPS business. Overall, InLoop is best understood as a healthcare-adjacent payments infrastructure and software company, not a biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InLoop.